Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

02/08/2018 07:00

Aug 2 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2018        Jun 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             2.70                2.71              11.10     
                 (-0.6 pct)          (-5.9 pct)        (+1.8 pct)   
  Operating        137 mln             134 mln        loss 510 mln  
                 (+2.0 pct)          (+7.3 pct)                     
  Recurring        151 mln             150 mln        loss 510 mln  
                 (+0.8 pct)          (+14.7 pct)                    
  Net              100 mln             99 mln         loss 380 mln  
                 (+0.9 pct)          (+16.5 pct)                    
  EPS             2.89 yen            2.87 yen       loss 10.95 yen 
  Ann Div                             3.00 yen                      
  -Q2 div                                NIL                        
  -Q4 div                             3.00 yen                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T